Neuro Assistant

50
Neuro Assistant
Neuro Assistant is an iOS app from Neuraxis AB in the Education category, currently rated 4.5★ across 12 ratings. Initial signal reads as no scraped reviews yet: judgment based on metadata only.
Quality Score is 50: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱MVP baseline (design + 1-store ship) | +$28K |
| 📱5 unique screens × $4.5K | +$22K |
| 📦Asset bundle (64 MB) | +$5K |
| ⚙Education complexity ×1.20 | +$11K |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Pre-traction · 39/100INDIE TIERlimited signal- 💰 Revenue: Modest — $727 - $4545/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.5★ across 12 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: last update 349d ago — slow cadence.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Paid app ($0.00)METRIC | +$2,800 | |
| Excellent rating (4.5★)METRIC | +$2,200 | |
| Mature app (8y old)METRIC | +$1,500 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (12 ratings)METRIC | −$300 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE📝 About this app
Neuro Assistant includes, among other features:
- Stroke syndromes reference, organised per-vessel.
- Cranial and peripheral nerves reference.
- Arterial perfusion and dermatome maps.
- Detailed anatomy reference of cerebral arteries and veins.
- Pharmacokinetics, dosing recommendations, interactions of all antiplatelet, anticoagulant, antiepileptic and antiparkinsonian drugs.… View full description on the official store →
🆕 What's New · v2.3.1
- Cluster headache summary
- Numerous small updates in Summaries module
Tech & Domain Intel — neuro-assistant.org
- Tech stack
- Google Workspace
Multi-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 0★ | 0 | — |
| 🇧🇷 BR | 5★ | 2 | 5★ this version |
| 🇨🇦 CA | 4★ | 1 | 4★ this version |
| 🇩🇪 DE | 0★ | 0 | — |
| 🇫🇷 FR | 0★ | 0 | — |
| 🇬🇧 GB | 5★ | 1 | 5★ this version |
| 🇮🇳 IN | 0★ | 0 | — |
| 🇯🇵 JP | 0★ | 0 | — |
| 🇺🇸 US | 4.5★ | 12 | 4.5★ this version |
Track this app’s revenue
FREEProfile & Insights
Identification
- App name
- Neuro Assistant
- Developer
- Neuraxis AB
- Bundle ID
- net.neuraxis.core.neuromancer
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $86/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📈Ratings growth12 ratings+33% lifetimeShow 3-year history estimate ▾
📝 Description
95
Why low confidence: only 12 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
Neuro Assistant is a early-stage iOS app in the education space with weak public traction — only 12 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.




